Cellectis

CLLS

ATLANTA, GA – – (Globe Newswire – September 17 2026) – – Holzer & Holzer, LLC is investigating whether Cellectis S.A. (“Cellectis” or the “Company”) (NASDAQ: CLLS) complied with federal securities laws. On September 14, 2026, Cellectis announced that it will “exit the development of lasme-cel and eti-cel[.]” On this news, the price of the Company’s stock dropped.

If you purchased Cellectis stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/cellectis/ to discuss your legal rights.

Registration Deadline

Lead Plaintiff Deadline Has Passed

Submit Your Information
Submit Your Form

Submit Your Information

Name(Required)
Address
Shares Purchased(Required)
Date of Shares Purchased
Number of Shares Acquired
Acquisition Price Per Share
 
Shares Sold
Date of Shares Sold
Number of Shares Sold
Selling Price Per Share
 
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.